Atlas Trials

IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

Clinical trial NCT00136994 · COMPLETED

Trial details

NCT number
NCT00136994
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2003-03-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.